April 22, 2026Journal of the American College of Cardiology1,076 citations
2020 ACC/AHA Guideline Summary for Managing Valvular Heart Disease
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary
Why the study?
This executive summary was developed to provide updated recommendations for clinicians to diagnose and manage valvular heart disease based on new evidence.
Population
Patients with valvular heart disease
Design
Clinical practice guideline executive summary based on a comprehensive literature search
Key result
The 2020 ACC/AHA executive summary provides updated evidence-based recommendations for the diagnosis, surgical and catheter interventions, and medical management of valvular heart disease.
Authors
Discussion
Loading...
Member takes
Key expert perspectives
Captured external expert commentary on this paper, strongest first. Original sources linked on every quote.
“Current research and new technology continue to transform the treatment of heart valve disease, as updated lifestyle and medication guidance evolve, and less invasive procedures have replaced traditional surgery for many patients.”
“From a patient's perspective, it would clearly be optimal for SAVR-only centers to facilitate their cardiologists (interventional and noninterventional) to either convene or direct patients to nearby institutions that do have a MDT evaluating patients with aortic valve disease. If a patient is ultimately rendered for SAVR, then they could be directed back to the referring institution.”
GAGorav AilawadiCardiac surgeon, University of Virginia
“As the number of TAVR centers expands, the number of SAVR-only centers is declining. Furthermore, to ensure guidelines are followed, SAVR-only centers will need to partner with local TAVR referral centers to complete the multidisciplinary evaluation for a shared decision-making approach with the patient.”
Overview
Clinicians should apply updated VHD recommendations to diagnosis and intervention decisions; extends 2014 guidelines with evidence on catheter therapies.
Key Points
- The aim is to summarize updated guidelines for diagnosing and managing valvular heart disease based on the latest evidence.
- Conducted literature search from January 1, 2010, to March 1, 2020.
- Included studies and reviews published in English from PubMed, EMBASE, and Cochrane.
- Focused on updates in diagnostic work-up and interventions including surgical and catheter options.
- Updated recommendations include newer diagnostic options for valvular heart disease.
- Recommendations emphasize timing and choice of surgical and catheter interventions.
- Guideline also provides medical therapy recommendations based on recent evidence.
Structured PICO
P
Population
Patients with valvular heart disease
I
Intervention
Diagnostic work-up, timing and choice of surgical and catheter interventions, and medical therapy
The 2020 ACC/AHA guideline provides updated, evidence-based recommendations for the diagnosis and management of valvular heart disease.
Cite This Study
Otto et al. (2020) conducted a review in Valvular heart disease. Guideline recommendations was evaluated. The 2020 ACC/AHA executive summary provides updated evidence-based recommendations for the diagnosis, surgical and catheter interventions, and medical management of valvular heart disease.